Intrexon Corp (XON) 25.33 $XON Purcell Julie & Lefkowitz

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Intrexon Corp (XON) 25.33 $XON

Purcell Julie & Lefkowitz LLP Is Investigating Intrexon Corporation for Potential Breaches Of Fiduciary Duty By Its Board of Directors
PR Newswire - Thu Sep 01, 6:21AM CDT
Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Intrexon Corporation (NYSE: XON).
XON: 25.33 (+0.04)

These Two Companies Are Working On The Zika Virus Cure
Ryan McQueeney - Zacks Investment Research - Wed Aug 31, 11:57AM CDT
As the Zika virus continues to spread, these two companies are looking to find the cure first.
INO: 9.08 (-0.06), XON: 25.33 (+0.04)

ZIOPHARM to Present at the 2016 Wells Fargo Healthcare Conference
GlobeNewswire - Wed Aug 31, 6:00AM CDT
ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP) today announced that Laurence Cooper, M.D., Ph.D., Chief Executive Officer, will present at the 2016 Wells Fargo Healthcare Conference on Wednesday, September 7, 2016 at 10:30 a.m. E.T. The conference is being held at the Westin Boston Waterfront.
ZIOP: 4.94 (-0.05), XON: 25.33 (+0.04), WFC: 50.55 (+0.12)

Oragenics Receives Supportive FDA Feedback for Initiating a Phase 2 Study Protocol for Oral Mucositis Treatment
BusinessWire - Tue Aug 30, 7:15AM CDT
Oragenics (NYSE MKT: OGEN.BC), a leader in the development of novel antibiotics against infectious disease and developing effective treatments for oral mucositis (OM) today announced that it has received feedback from the U.S. Food and Drug Administration (FDA) in response to the Company's request for a Type C meeting, concerning Phase 2 study protocols for the Company's OM therapeutic candidate, AG013. As part of the clinical protocol for the study, Oragenics expects to file the Investigational New Drug (IND) update in late 2016 and initiate the study with AG013 in the United States and Europe during early 2017.
XON: 25.33 (+0.04), OGEN: 0.68 (+0.03)

Inovio Stock Up as Second Zika Virus Vaccine Study Begins
Zacks Equity Research - Zacks Investment Research - Tue Aug 30, 7:07AM CDT
Inovio Pharmaceuticals' (INO) shares were up after the company started a second study evaluating its preventive Zika vaccine, GLS-5700, in Puerto Rico.
INO: 9.08 (-0.06), ANIP: 59.86 (-1.56), GERN: 2.75 (+0.02), XON: 25.33 (+0.04)

Learn how to target a 20% return on Apple, or get option-trade ideas on Resolute Energy Corporation, Autodesk, Intrexon and Energy Transfer Equity or any stock you choose
PR Newswire - Mon Aug 29, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for AAPL, ADSK, ETE, REN, and XON.
REN: 22.03 (+4.33), XON: 25.33 (+0.04), ETE: 17.84 (+0.03), AAPL: 107.73 (+1.00), ADSK: 68.01 (+0.64)

Oragenics Selects New Lantibiotic for Further Development in Clostridium difficile Infections
BusinessWire - Tue Aug 23, 7:15AM CDT
Oragenics (NYSE:MKT - OGEN.BC), a leader in the development of new antibiotics against infectious disease and developing effective treatments for oral mucositis, today announced selection of a second generation lantibiotic, OG716, for treatment of Clostridium difficile and plans to begin Investigational New Drug (IND) enabling studies.
XON: 25.33 (+0.04), OGEN: 0.68 (+0.03)

Covered Call reports for Gilead Sciences, Intrexon, Ralph Lauren, Smith & Wesson and Eros International include trade ideas that offer returns of 20% or more!
PR Newswire - Thu Aug 11, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for EROS, GILD, RL, SWHC, and XON.
GILD: 76.89 (-0.53), XON: 25.33 (+0.04), RL: 103.23 (-0.30), EROS: 16.57 (+0.24), SWHC: 27.69 (-1.89)

Arctic® Fuji apple one step closer to U.S. regulatory approval
PR Newswire - Thu Aug 11, 7:30AM CDT
The U.S. Department of Agriculture's (USDA) Animal and Plant Health Inspection Service (APHIS) has publicly shared the final version of Okanagan Specialty Fruits Inc.'s (OSF) petition seeking regulatory approval for Arctic® Fuji apples, a nonbrowning variety produced through biotechnology.
XON: 25.33 (+0.04)

Intrexon (XON) Reports Wider Loss in Q2, Revenues Increase
Zacks Equity Research - Zacks Investment Research - Wed Aug 10, 4:10PM CDT
Intrexon (XON) reported a loss of 42 cents per share in second-quarter 2016, compared to the year-ago figure of 37 cents.
ZIOP: 4.94 (-0.05), ANIP: 59.86 (-1.56), XON: 25.33 (+0.04)

Intrexon Announces Second Quarter and First Half 2016 Financial Results
PR Newswire - Tue Aug 09, 3:05PM CDT
Intrexon Corporation (NYSE: XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, today announced its second quarter and first half financial results for 2016.
ZIOP: 4.94 (-0.05), FCSC: 0.89 (-0.01), XON: 25.33 (+0.04)

ZIOPHARM Reports Second-Quarter 2016 Financial Results and Provides Update on Recent Activities
GlobeNewswire - Tue Aug 09, 3:01PM CDT
ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP) today announced financial results for the second quarter ended June 30, 2016, and provided an update on the Company's recent activities.
ZIOP: 4.94 (-0.05), XON: 25.33 (+0.04)

The Zacks Analyst Blog Highlights: Intrexon, PharMerica, Surgery Partners, Civitas Solutions and Healthways
Zacks Equity Research - Zacks Investment Research - Tue Aug 09, 8:30AM CDT
The Zacks Analyst Blog Highlights: Intrexon, PharMerica, Surgery Partners, Civitas Solutions and Healthways
SGRY: 20.04 (+0.91), PMC: 25.95 (+0.76), CIVI: 18.34 (+0.40), HWAY: 24.96 (+0.10), XON: 25.33 (+0.04)

Fibrocell Announces Proposed Public Offering of Common Stock and Warrants
GlobeNewswire - Mon Aug 08, 3:29PM CDT
Fibrocell Science, Inc. (NASDAQ:FCSC) (Fibrocell) today announced that it intends to offer and sell shares of its common stock and related warrants to purchase shares of its common stock in an underwritten public offering. The shares of common stock and related warrants will be immediately separable and will be issued separately. All of the securities in the offering are to be sold by Fibrocell.
FCSC: 0.89 (-0.01), XON: 25.33 (+0.04)

Healthcare Stocks' Aug 9 Earnings Roster: XON, PMC & More
Zacks Equity Research - Zacks Investment Research - Mon Aug 08, 8:09AM CDT
Here, we take a look at five healthcare stocks scheduled to report their quarterly figures on Aug 9.
SGRY: 20.04 (+0.91), PMC: 25.95 (+0.76), CIVI: 18.34 (+0.40), XON: 25.33 (+0.04), HWAY: 24.96 (+0.10)

Intrexon Appoints Dr. Andrew J. Last as Chief Operating Officer
PR Newswire - Mon Aug 08, 7:00AM CDT
Intrexon Corporation (NYSE: XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, today announced the appointment of Andrew J. Last, Ph.D., as Chief Operating Officer effective August 29, 2016, reporting to Intrexon's President, Geno Germano. As Chief Operating Officer, Dr. Last will oversee operations across the Company's multiple technology divisions and operating subsidiaries, driving efficiency and effectiveness in the application of the Company's assets toward its development projects, Exclusive Channel Collaborations and direct market plays.
XON: 25.33 (+0.04)

What's in Store for Intrexon (XON) This Earnings Season?
Zacks Equity Research - Zacks Investment Research - Mon Aug 08, 3:09AM CDT
Intrexon (XON), which is set to report second-quarter 2016 results on Aug 9, posted a negative surprise of 10.34% last quarter.
ADHD: 4.77 (+0.03), XON: 25.33 (+0.04), MCRB: 10.13 (-0.02), IONS: 29.46 (-0.58)

FDA Publishes Final Finding of No Significant Impact and Environmental Assessment on Oxitec's Self-limiting Mosquito
PR Newswire Europe - Fri Aug 05, 10:16AM CDT
The US Food and Drug Administration's Center for Veterinary Medicine (FDA-CVM) today published a final finding of no significant impact (FONSI) and final environmental assessment (EA) on Oxitec's self-limiting OX513A Aedes aegypti mosquito for an investigational trial in the Florida Keys. The finding concludes that a field trial of the Company's genetically engineered (GE) OX513A mosquitoes in Key Haven, Florida, will not result in a significant impact on the environment.
XON: 25.33 (+0.04)

MKS Instruments, Emerson Electric, Inovio Pharmaceuticals and Intrexon highlighted as Zacks Bull and Bear of the Day
Zacks Equity Research - Zacks Investment Research - Fri Aug 05, 8:30AM CDT
MKS Instruments, Emerson Electric, Inovio Pharmaceuticals and Intrexon highlighted as Zacks Bull and Bear of the Day
INO: 9.08 (-0.06), XON: 25.33 (+0.04), EMR: 52.91 (+0.25), MKSI: 49.60 (+0.35)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

China's APEC Summit: A Catalyst for Business Growth?

Updated Category News Views 48

A Shift Toward Regional Stability China's position as this year's APEC rotating chair presents both opportunity and challenge as economies grapple with trade barriers and technological upheaval. The 33rd APEC Economic Leaders' Meeting in Shenzhen is intended to navigate these turbulent waters, setting the stage for a more stable regional environment. APEC's Role in...

Continue Reading
Sue Egstrand to Lead Karo's Next Growth Phase

Updated Category News Views 117

A New Captain at Karo’s Helm Karo Healthcare is bracing for an exciting ride. Sue Egstrand’s appointment as the new CEO pulls the curtain on what might just be a game-changing era for the company. Set to take the wheel on January 1, 2027, Egstrand brings a heavy-hitting resume—a mash-up of pharmaceutical prowess and a deep-dive into consumer healthcare. Sue’s...

Continue Reading
Gaotu Techedu's Q3 Results: A Look at AI-Driven Growth

Updated Category News Views 56

Gaotu Techedu to Unveil Q3 Results Mark your calendars, folks—Gaotu Techedu Inc. (NYSE: GOTU) is gearing up to dish out its third quarter financial results on November 25, 2026. As usual, these numbers will slide out before the U.S. markets spring into action. It's one of those moments when investors like us strap in and watch for any movement that might toss our...

Continue Reading
Gold Tumbles: Kinross Faces Class Action Lawsuit

Updated Category News Views 79

Digging Deep into Kinross's Legal Fallout Well, here's a doozy for those investing in the precious metal market. Kinross Gold Corporation (NYSE: KGC) finds itself knee-deep in legal muck. Investors who bought into the Canadian gold miner's promises might be scrambling, as a class action lawsuit has just been lobbed their way. The culprit? A hefty drop-off in their...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 382

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
Atomera Preps for Key Craig-Hallum Conference

Updated Category News Views 59

Unpacking the NYC Gathering Alight, let's comb through the moving parts here. Atomera Inc., ticker NASDAQ: ATOM for those eyeing the dance of numbers, is all set to step into the limelight at the 17th Annual Craig-Hallum Alpha Select Conference on November 17, 2026. This shindig isn't just another date on the calendar; it's a strategic haunt where Atomera will rub...

Continue Reading
Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 421

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
Envision and Tsinghua Propel Climate Innovation at COP31

Updated Category News Views 87

Collaborating for a Greener Future On the bustling stage of COP31 in Antalya, Turkey, Envision Energy and Tsinghua University teamed up with the Global Alliance of Universities on Climate (GAUC) to showcase a bold agenda. Their focus transcends mere dialogue, pushing for actionable climate solutions anchored in technological innovation, academic synergy, and the dynamism...

Continue Reading
Roche Delivers Endotrophin Assay to Nordic Bioscience Lab

Updated Category News Views 52

Roche Opens New Frontier in Diagnostic Biomarkers Get ready to chew on this: Roche Diagnostics is bringing something new to Nordic Bioscience's CLIA lab. They're offering up their Endotrophin research prototype assay on the cobas® e801 Analyzer. Now, what does this mean for the scientific world? Well, it might just shake things up for those battling cardiovascular and...

Continue Reading
Asia-Pacific Miracle: New Economic Chapter Unfolds

Updated Category News Views 87

A Fresh Breeze in Asia-Pacific's Sails You ever look around and realize everything's about to change—again? That's Asia-Pacific right now. We're staring down the barrel of a new chapter in what folks are calling the "Asia-Pacific miracle." The text from China Daily paints a picture of a region gearing up to crank the cooperation dial even higher. And where's this...

Continue Reading

Top 5 Most Recently Viewed Articles

Empowering Voices: Chicago's Latina Trailblazers Unite

Updated Category News Views 156

Empowering Voices: Chicago's Latina Trailblazers Unite The Chicago History Museum is set to host a remarkable celebration of the book, Chicago Latina Trailblazers. This event recognizes the contributions of remarkable Latina leaders through compelling narratives of activism and community service. Event Overview On a significant date that marks a celebration of Latina...

Continue Reading
Mark Green to Keynote CyberScape Summit Focused on Cybersecurity

Updated Category News Views 132

Mark Green to Keynote CyberScape Summit U.S. House Homeland Security Committee Chairman Mark Green is set to showcase his insights as the keynote speaker for GovCIO Media & Research's CyberScape Summit. The event promises to be an essential gathering for those interested in advancing cybersecurity practices and policies within the government. Focus on Cybersecurity and...

Continue Reading
Brian D. Pieninck Takes Leadership Role at GuideWell

Updated Category News Views 539

Brian D. Pieninck Assumes Role as GuideWell President & CEO GuideWell Mutual Holding Corporation has recently made a significant executive decision by appointing Brian D. Pieninck as the new president and chief executive officer (CEO), effective October 1. Previously, Pieninck served as the president and CEO of CareFirst BlueCross BlueShield and was the Board Chair for...

Continue Reading
Calidi Biotherapeutics Unveils Promising CLD-401 Data at SITC

Updated Category News Views 175

Calidi Biotherapeutics Showcases CLD-401 at SITC Calidi Biotherapeutics, Inc. (NYSE: CLDI), a clinical-stage biotechnology firm, recently presented impactful new data regarding its lead therapeutic candidate CLD-401 during the Society for Immunotherapy of Cancer (SITC) Annual Meeting. This presentation highlighted the innovative capabilities of Calidi’s RedTail...

Continue Reading
Everlight Solar: Milwaukee's Top Pick for Eco Energy

Updated Category News Views 21

A High Wattage Win for Everlight Solar Milwaukee seems to have found its favorite solar squad, and it’s none other than Everlight Solar, folks. They’ve locked in the 2026 Milwaukee's Top Choice in the Solar Services Company category. Now, that’s a badge you wear with pride when it's handed out by the very community you serve. It's not every day you see a company...

Continue Reading